Real-World Efficacy of Second-Line Reportorial in Patients With Advanced None Small-Cell Lung Cancer
Write a research paper that clarify the real-world efficacy and safety of second-line Reportorial, assessed 95 consecutive patients with advanced none small-cell lung cancer in a retrospective multi center trial.
Non adenocarcinoma and a large number of metastatic sites correlated with poor progression-free survival (PFS). PFS and overall survival (OS) were longer in patients with embolization-related adverse events;
however, PFS and OS were shorter in patients with interstitial lung disease
Write a research paper that clarify the real-world efficacy and safety of second-line Reportorial, assessed 95 consecutive patients with advanced none small-cell lung cancer in a retrospective multi center trial.
